We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
Updated: 1/1/1970
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Updated: 1/1/1970
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
Updated: 1/1/1970
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Updated: 1/1/1970
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
Updated: 1/1/1970
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Updated: 1/1/1970
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
Updated: 1/1/1970
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Updated: 1/1/1970
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
Updated: 1/1/1970
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Updated: 1/1/1970
Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect on Insulin Requirements After Supplementation With Vitamin D
Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect on Insulin Requirements After Supplementation With Vitamin D-A Pilot Study
Status: Archived
Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect on Insulin Requirements After Supplementation With Vitamin D
Updated: 1/1/1970
Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect on Insulin Requirements After Supplementation With Vitamin D-A Pilot Study
Status: Archived
Updated: 1/1/1970
Isoflurane Preconditioning for Liver Resections
Isoflurane Induced Anesthetic Preconditioning in Elective Liver Resection
Status: Archived
Isoflurane Preconditioning for Liver Resections
Updated: 1/1/1970
Isoflurane Induced Anesthetic Preconditioning in Elective Liver Resection
Status: Archived
Updated: 1/1/1970
Confocal Laser Endomicroscopy for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
Status: Archived
Confocal Laser Endomicroscopy for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Confocal Laser Endomicroscopy for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
Status: Archived
Confocal Laser Endomicroscopy for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Confocal Laser Endomicroscopy for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
Status: Archived
Confocal Laser Endomicroscopy for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Confocal Laser Endomicroscopy for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
Status: Archived
Confocal Laser Endomicroscopy for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
Status: Archived
Updated: 1/1/1970
Updated: 1/1/1970
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
Comparison of Immune Response to the Human Papillomavirus Vaccine in Young Women With and Without Inflammatory Bowel Disease
Status: Archived
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
Updated: 1/1/1970
Comparison of Immune Response to the Human Papillomavirus Vaccine in Young Women With and Without Inflammatory Bowel Disease
Status: Archived
Updated: 1/1/1970
Electrohydraulic Versus Laser Lithotripsy
Electrohydraulic Versus Laser Lithotripsy for Difficult to Remove Biliary Stones: A Randomized Study
Status: Archived
Electrohydraulic Versus Laser Lithotripsy
Updated: 1/1/1970
Electrohydraulic Versus Laser Lithotripsy for Difficult to Remove Biliary Stones: A Randomized Study
Status: Archived
Updated: 1/1/1970
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
Status: Archived
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
Updated: 1/1/1970
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
Status: Archived
Updated: 1/1/1970
Same-day, Reduced Volume Bowel Preparation
Evaluating the Effectiveness of a Same-day, Reduced Volume Polyethylene Glycol + Electrolyte Solution (PEG-ELS) Bowel Preparation for Afternoon Colonoscopies
Status: Archived
Same-day, Reduced Volume Bowel Preparation
Updated: 1/1/1970
Evaluating the Effectiveness of a Same-day, Reduced Volume Polyethylene Glycol + Electrolyte Solution (PEG-ELS) Bowel Preparation for Afternoon Colonoscopies
Status: Archived
Updated: 1/1/1970
Provant Therapy of Venous Stasis Ulcer Trial
Provant Therapy of Venous Stasis Ulcer Trial
Status: Archived
Provant Therapy of Venous Stasis Ulcer Trial
Updated: 1/1/1970
Provant Therapy of Venous Stasis Ulcer Trial
Status: Archived
Updated: 1/1/1970
Provant Therapy of Venous Stasis Ulcer Trial
Provant Therapy of Venous Stasis Ulcer Trial
Status: Archived
Provant Therapy of Venous Stasis Ulcer Trial
Updated: 1/1/1970
Provant Therapy of Venous Stasis Ulcer Trial
Status: Archived
Updated: 1/1/1970
Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity
Status: Archived
Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity
Updated: 1/1/1970
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity
Status: Archived
Updated: 1/1/1970
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
The Role of Intestinal Inflammation in the Pathophysiology of IBS
Status: Archived
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
Updated: 1/1/1970
The Role of Intestinal Inflammation in the Pathophysiology of IBS
Status: Archived
Updated: 1/1/1970
Effect of Intermittent Pneumatic Compression on Ulcer Healing in Subjects With Secondary Lymphedema
Intermittent, Gradient, Pneumatic Compression Plus Standard Compression for Hard-To-Heal Venous Ulcers in Subjects With Secondary Lymphedema and Chronic Venous Insufficiency
Status: Archived
Effect of Intermittent Pneumatic Compression on Ulcer Healing in Subjects With Secondary Lymphedema
Updated: 1/1/1970
Intermittent, Gradient, Pneumatic Compression Plus Standard Compression for Hard-To-Heal Venous Ulcers in Subjects With Secondary Lymphedema and Chronic Venous Insufficiency
Status: Archived
Updated: 1/1/1970
Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus
Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus
Status: Archived
Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus
Updated: 1/1/1970
Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
Updated: 1/1/1970
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Mastery Learning Inguinal Hernia Repair
Mastery Learning Totally Extraperitoneal Inguinal Hernia Repair: Linking Surgical Simulation to Patient Level Outcomes
Status: Archived
Mastery Learning Inguinal Hernia Repair
Updated: 1/1/1970
Mastery Learning Totally Extraperitoneal Inguinal Hernia Repair: Linking Surgical Simulation to Patient Level Outcomes
Status: Archived
Updated: 1/1/1970
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
Status: Archived
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
Updated: 1/1/1970
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
Status: Archived
Updated: 1/1/1970
Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Gluten Intolerance in Irritable Bowel Syndrome With Diarrhea: The Role of HLA-DQ2
Status: Archived
Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Updated: 1/1/1970
Gluten Intolerance in Irritable Bowel Syndrome With Diarrhea: The Role of HLA-DQ2
Status: Archived
Updated: 1/1/1970
Improving Bowel Preparation With an Educational Video
Improving Bowel Preparation With an Education Video
Status: Archived
Improving Bowel Preparation With an Educational Video
Updated: 1/1/1970
Improving Bowel Preparation With an Education Video
Status: Archived
Updated: 1/1/1970
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Updated: 1/1/1970
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
Updated: 1/1/1970
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Updated: 1/1/1970
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
Updated: 1/1/1970
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Updated: 1/1/1970
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
Updated: 1/1/1970
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Updated: 1/1/1970
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
Updated: 1/1/1970
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Updated: 1/1/1970
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
Updated: 1/1/1970
Utility of a Urine Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Utility of the Urine Calcium Creatinine Ratio as a Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Status: Archived
Utility of a Urine Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Updated: 1/1/1970
Utility of the Urine Calcium Creatinine Ratio as a Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Status: Archived
Updated: 1/1/1970
Use of INTEGRAâ„¢ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
The Use of INTEGRAâ„¢ Flowable Wound Matrix to Manage Diabetic Foot Ulcers in High Risk Populations: A Prospective, Randomized, Controlled Trial
Status: Archived
Use of INTEGRAâ„¢ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
Updated: 1/1/1970
The Use of INTEGRAâ„¢ Flowable Wound Matrix to Manage Diabetic Foot Ulcers in High Risk Populations: A Prospective, Randomized, Controlled Trial
Status: Archived
Updated: 1/1/1970
Assessment of Gastric Emptying Speed in Patients Who Experience Diarrhea Following a Trigger Meal
Pilot Study: Assessment of Gastric and Intestinal Motility Following a Trigger Meal in Patients With Post Prandial Diarrhea
Status: Archived
Assessment of Gastric Emptying Speed in Patients Who Experience Diarrhea Following a Trigger Meal
Updated: 1/1/1970
Pilot Study: Assessment of Gastric and Intestinal Motility Following a Trigger Meal in Patients With Post Prandial Diarrhea
Status: Archived
Updated: 1/1/1970
Vagal Nerve Stimulation and Glucose Metabolism
The Effect of Vagal Nerve Stimulation on Enteroendocrine Secretion and Glucose Metabolism
Status: Archived
Vagal Nerve Stimulation and Glucose Metabolism
Updated: 1/1/1970
The Effect of Vagal Nerve Stimulation on Enteroendocrine Secretion and Glucose Metabolism
Status: Archived
Updated: 1/1/1970
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
Updated: 1/1/1970
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
Updated: 1/1/1970
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
Updated: 1/1/1970
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
Updated: 1/1/1970
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
Updated: 1/1/1970
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
Updated: 1/1/1970